{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:01:27Z","timestamp":1790420487376,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40265-016-0582-3","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T12:38:25Z","timestamp":1462538305000},"page":"915-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Ongoing Pharmacological Management of Chronic Pain in Pregnancy"],"prefix":"10.1007","volume":"76","author":[{"given":"Bengt","family":"K\u00e4ll\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","unstructured":"Broussard CS, Rasmussen S, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obst Gynecol 2011; 204:314.e1\u201311.","DOI":"10.1016\/j.ajog.2010.12.039"},{"key":"582_CR2","volume-title":"Birth defects and drugs in pregnancy","author":"OP Heinonen","year":"1977","unstructured":"Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: Mass. Publishing Sciences Group. Inc.; 1977."},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ije\/dyl170","volume":"35","author":"P Magnus","year":"2006","unstructured":"Magnus P, Irgens LM, Haug K, et al. Cohort profile: The Norwegian Mother and Chikld Cohort Study (MoBa). Int J Epidemiol. 2006;35:1146\u201350.","journal-title":"Int J Epidemiol"},{"key":"582_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/14034948010290040201","volume":"29","author":"J Olsen","year":"2001","unstructured":"Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort\u2014its background, structure and aim. Scand J Publ Health. 2001;29:300\u20137.","journal-title":"Scand J Publ Health"},{"key":"582_CR5","doi-asserted-by":"crossref","unstructured":"K\u00e4ll\u00e9n B, Otterblad Olausson P. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Safety Med 2001;14:135\u201349. http:\/\/www.socialstyrelsen.se\/Publikationer2003\/2003-112-3 . Access data 4 April 2016.","DOI":"10.3233\/JRS-2001-263"},{"key":"582_CR6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/aje\/kwk027","volume":"165","author":"PP Howards","year":"2007","unstructured":"Howards PP, Hertz-Piciotto I, Poole I. Conditions from differential left truncation. Am J Epidemiol. 2007;165:444\u201352.","journal-title":"Am J Epidemiol"},{"key":"582_CR7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","volume":"183","author":"H Nakhai-Pour","year":"2011","unstructured":"Nakhai-Pour H, Broy P, Sheehy O, B\u00e9rard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011;183:1713\u20139.","journal-title":"CMAJ"},{"key":"582_CR8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1526-4610.2012.02172.x","volume":"52","author":"A B\u00e9rard","year":"2012","unstructured":"B\u00e9rard A, Kori S. Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes. Headache. 2012;52:1085\u201392.","journal-title":"Headache"},{"key":"582_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0b013e3182595671","volume":"120","author":"DR Edwards","year":"2012","unstructured":"Edwards DR, Aldridge T, Baird DD, et al. Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk of spontaneous abortion. Obstet Gynecol. 2012;120:113\u201322.","journal-title":"Obstet Gynecol"},{"issue":"397","key":"582_CR10","first-page":"e1","volume":"212","author":"S Daniel","year":"2015","unstructured":"Daniel S, Koren G, Lunenfeld E, Levy A. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure. Am J Obstet Gynecol. 2015;212(397):e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"582_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","volume":"327","author":"L De-Kun","year":"2003","unstructured":"De-Kun L, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarrage: population based cohort study. BMJ. 2003;327:368.","journal-title":"BMJ"},{"key":"582_CR12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ije\/dyp151","volume":"38","author":"C Rebordosa","year":"2009","unstructured":"Rebordosa C, Kogevinas M, Bech BH. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int J Epidemiol. 2009;38:706\u201314.","journal-title":"Int J Epidemiol"},{"key":"582_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/tera.1420450407","volume":"45","author":"MM Werler","year":"1992","unstructured":"Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology. 1992;45:361\u20137.","journal-title":"Teratology"},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","volume":"155","author":"MM Werler","year":"2002","unstructured":"Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol. 2002;155:26\u201331.","journal-title":"Am J Epidemiol"},{"key":"582_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdra.10001","volume":"67","author":"MM Werler","year":"2004","unstructured":"Werler MM, Louik C, Mitchell AA. Epidemiological analysis of maternal factors and amniotic band defects. Birth Def Res (Part A). 2004;67:68\u201372.","journal-title":"Birth Def Res (Part A)"},{"key":"582_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","volume":"54","author":"CP Torfs","year":"1996","unstructured":"Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJR. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology. 1996;54:84\u201392.","journal-title":"Teratology"},{"key":"582_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1","volume":"56","author":"ML Martinez-Fr\u00edas","year":"1997","unstructured":"Martinez-Fr\u00edas ML, Rodr\u00edguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology. 1997;56:241\u20133.","journal-title":"Teratology"},{"key":"582_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000263620","volume":"6","author":"RA Drongowski","year":"1991","unstructured":"Drongowski RA, Smith RK Jr, Coran AG, Klein MD. Contribution of demographic and environmental factors to the etiology of gastroschisis: a hypothesis. Fetal Diagn Ther. 1991;6:14\u201327.","journal-title":"Fetal Diagn Ther"},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2007-993879","volume":"16","author":"AM Thulstrup","year":"1999","unstructured":"Thulstrup AM, S\u00f8rensen HT, Nielsen GL, et al. Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group. Am J Perinatol. 1999;16:321\u20136.","journal-title":"Am J Perinatol"},{"key":"582_CR20","doi-asserted-by":"crossref","unstructured":"Rebordosa C, Kogevinas M, Horv\u00e1th-Puh\u00f3 E, et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obst Gynecol 2008;198:178.e1\u20137.","DOI":"10.1016\/j.ajog.2007.08.040"},{"key":"582_CR21","volume-title":"Drugs during Pregnancy","author":"B K\u00e4ll\u00e9n","year":"2009","unstructured":"K\u00e4ll\u00e9n B. Drugs during Pregnancy. New York: Nova Biomedical Books; 2009."},{"key":"582_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","volume":"322","author":"GL Nielsen","year":"2001","unstructured":"Nielsen GL, S\u00f8rensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control. BMJ. 2001;322:266\u201370.","journal-title":"BMJ"},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","volume":"15","author":"A NieEricsonlsen","year":"2001","unstructured":"Ericson A, K\u00e4ll\u00e9n BAJ. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol. 2001;15:371\u20135.","journal-title":"Reprod Toxicol"},{"key":"582_CR24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","volume":"77","author":"B Ofori","year":"2006","unstructured":"Ofori B, Oraichi D, Blais L, Ray E, B\u00e9rard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Def Res (Part B). 2006;77:268\u201379.","journal-title":"Birth Def Res (Part B)"},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2125.2007.02901.x","volume":"64","author":"H B\u00e1nhidy","year":"2007","unstructured":"B\u00e1nhidy H, \u00c1cs N, Puh\u00f3 E, Czeizel AE. Ergotamine treatment during pregnancy and a higher rate of low birth weight and preterm birth. Br J Clin Pharmacol. 2007;64:510\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"582_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10654-013-9831-x","volume":"28","author":"K Nezvalov\u00e1-Henriksen","year":"2013","unstructured":"Nezvalov\u00e1-Henriksen K, Spigset O, Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol. 2013;28:759\u201369.","journal-title":"Eur J Epidemiol"},{"key":"582_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/humrep\/deq323","volume":"26","author":"DM Kristensen","year":"2011","unstructured":"Kristensen DM, Hass U, Lesn\u00e9 L, et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod. 2011;26:235\u201344.","journal-title":"Hum Reprod"},{"key":"582_CR28","doi-asserted-by":"crossref","unstructured":"S\u00f8ndergaard Jensen M, Rebordosa C, Thulstrup AM et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010;21:779\u201385.","DOI":"10.1097\/EDE.0b013e3181f20bed"},{"key":"582_CR29","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/humrep\/der474","volume":"27","author":"CA Snidjer","year":"2012","unstructured":"Snidjer CA, Kortenkamp A, Steegers EAP, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring. The Generation R Study. Hum Reprod. 2012;27:1191\u2013201.","journal-title":"Hum Reprod"},{"key":"582_CR30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2004.07.004","volume":"119","author":"B Bar-Oz","year":"2005","unstructured":"Bar-Oz B, Clementi M, Giantonio ED, et al. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2005;119:176\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00002018-200730010-00006","volume":"30","author":"H B\u00e1nhidy","year":"2007","unstructured":"B\u00e1nhidy H, \u00c1cs N, Puh\u00f3 E, Czeizel AE. A population-based case-control teratologic study of oral dipyrone treatment during pregnancy. Drug Saf. 2007;30:59\u201370.","journal-title":"Drug Saf"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","volume":"17","author":"B K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n B, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17:255\u201363.","journal-title":"Reprod Toxicol"},{"key":"582_CR33","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/AOG.0b013e3182a6643c","volume":"122","author":"MM Yazdy","year":"2013","unstructured":"Yazdy MM, Mitchell AA, Tinker SC, Parker S, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol. 2013;122:838\u201344.","journal-title":"Obstet Gynecol"},{"key":"582_CR34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","volume":"67","author":"K Nezvalov\u00e1-Henriksen","year":"2011","unstructured":"Nezvalov\u00e1-Henriksen K, Spigset O, Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol. 2011;67:1253\u201361.","journal-title":"Eur J Clin Pharmacol"},{"key":"582_CR35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.reprotox.2015.10.007","volume":"58","author":"B K\u00e4ll\u00e9n","year":"2015","unstructured":"K\u00e4ll\u00e9n B, Reis M. Use of tramadol in early pregnancy and congenital malformation risk. Reprod Toxicol. 2015;58:246\u201351.","journal-title":"Reprod Toxicol"},{"key":"582_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1526-4610.2002.02007.x","volume":"42","author":"AW Fox","year":"2002","unstructured":"Fox AW, Chambers CD, Anderson PO, et al. Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache. 2002;42:8\u201315.","journal-title":"Headache"},{"key":"582_CR37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1526-4610.2001.111006351.x","volume":"41","author":"B K\u00e4ll\u00e9n","year":"2001","unstructured":"K\u00e4ll\u00e9n B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache. 2001;41:351\u20136.","journal-title":"Headache"},{"key":"582_CR38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.reprotox.2006.03.002","volume":"22","author":"N \u00c1cs","year":"2006","unstructured":"\u00c1cs N, B\u00e1nhidy F, Puh\u00f3 E, Czeizel AE. A possible dose-dependent teratogenic effect of ergotamine. Letter to the Editor. Reprod Toxicol. 2006;22:551\u20132.","journal-title":"Reprod Toxicol"},{"key":"582_CR39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11590370-000000000-00000","volume":"34","author":"B K\u00e4ll\u00e9n","year":"2011","unstructured":"K\u00e4ll\u00e9n B, Nilsson E. Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine. Drug Safety. 2011;34:691\u2013702.","journal-title":"Drug Safety"},{"key":"582_CR40","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1526-4610.2009.01529.x","volume":"49","author":"M Cunnington","year":"2009","unstructured":"Cunnington M, Ephross S, Churchill P. The safety of sumatriptan and naratriptan in pregnancy. What have we learned? Headache. 2009;49:1414\u201322.","journal-title":"Headache"},{"key":"582_CR41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1526-4610.2010.01619.x","volume":"50","author":"K Nezvalov\u00e1-Henriksen","year":"2010","unstructured":"Nezvalov\u00e1-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache. 2010;50:563\u201375.","journal-title":"Headache"},{"key":"582_CR42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/head.12500","volume":"55","author":"A Marchenko","year":"2015","unstructured":"Marchenko A, Etwel F, Olutunfese O, et al. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache. 2015;55:490\u2013501.","journal-title":"Headache"},{"key":"582_CR43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejogrb.2014.08.013","volume":"181","author":"T Guttoso Jr","year":"2014","unstructured":"Guttoso T Jr, Shaman M, Thornburg LI. Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;181:280\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"582_CR44","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","volume":"6","author":"B K\u00e4ll\u00e9n","year":"2013","unstructured":"K\u00e4ll\u00e9n B, Borg N, Reis M. The use of central nervous system active drugs during pregnancy. Parmaceuticals. 2013;6:1221\u201386.","journal-title":"Parmaceuticals"},{"key":"582_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12497","author":"D Lassen","year":"2015","unstructured":"Lassen D. Nymand Ennis Z, Damkier P. First trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol. 2015. doi: 10.1111\/bcpt.12497 .","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"582_CR46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/14767050903334877","volume":"23","author":"C Rebordosa","year":"2010","unstructured":"Rebordosa C, Zelop CM, Kogevinas M, S\u00f8rensen HT, Olsen J. Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort. J Mat-Fetal Neonatal Med. 2010;23:371\u20138.","journal-title":"J Mat-Fetal Neonatal Med"},{"key":"582_CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0897.1992.tb00777.x","volume":"28","author":"A Schoenfield","year":"1992","unstructured":"Schoenfield A, Bar Y, Merlop P, Ovadia Y. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol. 1992;28:141\u20137.","journal-title":"Am J Reprod Immunol"},{"key":"582_CR48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/138920012800166607","volume":"13","author":"R Antonucci","year":"2012","unstructured":"Antonucci R, Zafanello M, Puxeddo E, et al. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. 2012;13:474\u201390.","journal-title":"Curr Drug Metab"},{"key":"582_CR49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","volume":"131","author":"LJ Marter Van","year":"2013","unstructured":"Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Nonsteroidal anti-inflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics. 2013;131:79\u201387.","journal-title":"Pediatrics"},{"key":"582_CR50","doi-asserted-by":"publisher","first-page":"h2102","DOI":"10.11.36\/bmj.h2102","volume":"350","author":"RI Desai","year":"2015","unstructured":"Desai RI, Huybrechts KF, Hernandez-Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350:h2102. doi: 10.11.36\/bmj.h2102 .","journal-title":"BMJ"},{"key":"582_CR51","doi-asserted-by":"publisher","unstructured":"Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry 2014; 14:104. http:\/\/www.biomedcentral.com\/1471-244X\/14\/104 . Correction in BMC Psychiatry 2015;15:134. doi: 10.1186\/s12888-015-0438-5 .","DOI":"10.1186\/s12888-015-0438-5"},{"key":"582_CR52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/ijamh.2012.016","volume":"24","author":"T Sithisarn","year":"2012","unstructured":"Sithisarn T, Granger DT, Bada HS. Consequences of prenatal substance use. Int J Adolesc Med Health. 2012;24:105\u201312.","journal-title":"Int J Adolesc Med Health"},{"key":"582_CR53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/tera.1420350207","volume":"35","author":"AP Streissguth","year":"1987","unstructured":"Streissguth AP, Treder RP, Barr HM, et al. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987;35:211\u20139.","journal-title":"Teratology"},{"key":"582_CR54","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/ije\/dyt183","volume":"42","author":"RE Brandlistuen","year":"2013","unstructured":"Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42:1702\u201313.","journal-title":"Int J Epidemiol"},{"key":"582_CR55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee P-C, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168:313\u201320.","journal-title":"JAMA Pediatr"},{"key":"582_CR56","doi-asserted-by":"crossref","first-page":"e108210","DOI":"10.1371\/journal.pone.0108210","volume":"9","author":"JMD Thompson","year":"2014","unstructured":"Thompson JMD, Waldie KE, Wall CR, et al. Associations between acetaminophen use during pregnancy and ADHD symptoms measured as ages 7 and 11 years. PlosOne. 2014;9:e108210.","journal-title":"PlosOne"},{"key":"582_CR57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/dmcn.12745","volume":"57","author":"L Fays De","year":"2015","unstructured":"De Fays L, van Malderen K, de Smet K, et al. Use of paracetamol during pregnancy and child neurological development. Dev Med Child Neurol. 2015;57:718\u201324.","journal-title":"Dev Med Child Neurol"},{"key":"582_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015606469","author":"RM Hoover","year":"2015","unstructured":"Hoover RM, Gombert VA, Erramouspe J. Association between prenatal acetaminophen exposure and future risk of attention deficit\/hyperactivity disorder in children. Ann Pharmacother. 2015. doi: 10.1177\/1060028015606469 .","journal-title":"Ann Pharmacother"},{"key":"582_CR59","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.185.5.366","volume":"185","author":"HJ S\u00f8rensen","year":"2004","unstructured":"S\u00f8rensen HJ, Mortensen EL, Renisch JM, Mednick SA. Association between prenatal exposure to analgesics and risk of schizophrenia. Br J Psychiatry. 2004;185:366\u201371.","journal-title":"Br J Psychiatry"},{"key":"582_CR60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2010.10.021","volume":"126","author":"L Gunawardana","year":"2011","unstructured":"Gunawardana L, Zammit S, Lewis G, et al. Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence. Schizophrenia Res. 2011;126:220\u20135.","journal-title":"Schizophrenia Res"},{"key":"582_CR61","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/thorax.57.11.958","volume":"57","author":"SO Shaheen","year":"2002","unstructured":"Shaheen SO, Newson RB, Sherriff A, et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax. 2002;57:958\u201363.","journal-title":"Thorax"},{"key":"582_CR62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2222.2005.02151.x","volume":"35","author":"SO Shaheen","year":"2005","unstructured":"Shaheen SO, Newson RB, Henderson AJ, et al. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy. 2005;35:18\u201325.","journal-title":"Clin Exp Allergy"},{"key":"582_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-303043","author":"M Cheelo","year":"2012","unstructured":"Cheelo M, Lodge CJ, Dharmage SC, et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis. Arch Dis Child. 2012. doi: 10.1136\/archdischild-2012-303043 .","journal-title":"Arch Dis Child"},{"key":"582_CR64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pai.12034","volume":"24","author":"B K\u00e4ll\u00e9n","year":"2013","unstructured":"K\u00e4ll\u00e9n B, Finnstr\u00f6m O, Nygren K-G. Otterblad Olausson P. Maternal drug use during pregnancy and asthma risk among children. Pediatr Allergy Immunol. 2013;24:28\u201332.","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0582-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-016-0582-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0582-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T01:13:03Z","timestamp":1748913183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-016-0582-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s40265-016-0582-3","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}